ARCHIVES

SEC Notifies ImClone It May Bring Action Against Company

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

Letter to the Editor: Expanding the Horizons Of Proton Beam Therapy

August 1, 2014

DCT’s Experimental Therapeutic Program Outlined to Board

May 2, 1975

House, Senate Reform Bills Move Closer To Floor Vote

August 12, 1994

DCT To Announce June 1 Guidelines For CREG Program In Cell Kinetics Related To Chemo, Radiotherapy

April 25, 1975

New Cyclotron Delivered To University of Maryland, Instigating D.C.-Area Proton Radiation Competition

June 20, 2014